The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
A Genome-Wide View of the In vitro Response to l-Asparaginase in Acute Lymphoblastic Leukemia
Abstract
To investigate the effect of l-asparaginase on acute lymphoblastic leukemia (ALL), we used cDNA microarrays to obtain a genome-wide view of gene expression both at baseline and after in vitro exposure to l-asparaginase in cell lines and pediatric ALL samples. In 16 cell lines, a baseline gene expression pattern distinguished l-asparaginase sensitivity from resistance. However, for 28 pediatric ALL samples, no consistent baseline expression pattern was associated with sensitivity to l-asparaginase. In particular, baseline expression of asparagine synthetase (ASNS) was not predictive of response to l-asparaginase. After exposure to l-asparaginase, 5 cell lines and 10 clinical samples exhibited very similar changes in the expression of a large number of genes. However, the gene expression changes occurred more slowly in the clinical samples. These changes included a consistent increase in expression of tRNA synthetases and solute transporters and activating transcription factor and CCAAT/enhancer binding protein family members, a response similar to that observed with amino acid starvation. There was also a consistent decrease in many genes associated with proliferation. Taken together, the changes seem to reflect a consistent coordinated response to asparagine starvation in both cell lines and clinical samples. Importantly, in the clinical samples, increased expression of ASNS after l-asparaginase exposure was not associated with in vitro resistance to l-asparaginase, indicating that ASNS-independent mechanisms of in vitro l-asparaginase resistance are common in ALL. These results suggest that targeting particular genes involved in the response to amino acid starvation in ALL cells may provide a novel way to overcome l-asparaginase resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, genome-wide analysis has shown that there is no consistent gene expression pattern that dictates sensitivity to L-asparaginase (Fine et al., 2005).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Fine et al., 2005
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F. Z., Miled, S. B., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,785
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
Schena, M., Shalon, D., Davis, R. W., & Brown, P. O. (1995) · Science · doi:10.1126/science.270.5235.467 · Cited by 9,609
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,524
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,931
Tkachuk, D., Köhler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 913
Pui, C., & Evans, W. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390907 · Cited by 841
Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O. D., Cimino, G. G., Croce, C. M., & Canaani, E. (1992) · Cell · doi:10.1016/0092-8674(92)90603-a · Cited by 822
Natarajan, K., Meyer, M. R., Jackson, B. M., Slade, D., Roberts, C., Hinnebusch, A. G., & Marton, M. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4347-4368.2001 · Cited by 749
Kamps, M. P., Murre, C., Sun, X.-H., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90658-2 · Cited by 695
High-fidelity mRNA amplification for gene profiling
Wang, E., Miller, L. D., Ohnmacht, G. A., Liu, E. T., & Marincola, F. M. (2000) · Nature Biotechnology · doi:10.1038/74546 · Cited by 675
Nourse, J. L., Mellentin, J. D., Galili, N., Wilkinson, J., Stanbridge, E. J., Smith, S. D., & Cleary, M. L. (1990) · Cell · doi:10.1016/0092-8674(90)90657-z · Cited by 661
Proposals for immunological classification of acute leukemias.
van Dongen, J. J. M. (1995) · PubMed · Cited by 543
Proposals for the immunological classification of acute leukemias.
Paietta, E. M. (1995) · PubMed · Cited by 503
Stong, R. C., Korsmeyer, S. J., Parkin, J. L., Arthur, D., & Kersey, J. (1985) · Blood · doi:10.1182/blood.v65.1.21.21 · Cited by 327
Fusion of the Leucine Zipper Gene HLF to the E2A Gene in Human Acute B-Lineage Leukemia
Inaba, T., Roberts, W. M., Shapiro, L. H., Jolly, K. W., Raimondi, S. C., Smith, S. D., & Look, A. T. (1992) · Science · doi:10.1126/science.1386162 · Cited by 287
Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., van Zantwijk, C. H., Smets, L. A., van Wering, E. R., & den Berg, A. V. D. D.-V. (1997) · Blood · doi:10.1182/blood.v90.7.2723 · Cited by 272
Self-citationPhenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line
Rosenfeld, C., Goutner, A., Choquet, C., Vénuat, A. M., Kayibanda, B., Pico, J. L., & Greaves, M. F. (1977) · Nature · doi:10.1038/267841a0 · Cited by 248
Characterization of a leukemic cell line of the pre‐B phenotype
Hurwitz, R. L., Hozier, J. C., LeBien, T. W., Minowada, J., Gajl-Peczalska, K., Kubonishi, I., & Kersey, J. (1979) · International Journal of Cancer · doi:10.1002/ijc.2910230206 · Cited by 246
Hunger, S. P., Ohyashiki, K., Toyama, K., & Cleary, M. L. (1992) · Genes & Development · doi:10.1101/gad.6.9.1608 · Cited by 239
Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines
Lange, B. J., Valtieri, M., Santoli, D., Caracciolo, D., Mavilio, F., Gemperlein, I., Griffin, C. A., Emanuel, B. S., Finan, J. B., & Nowell, P. C. (1987) · Blood · doi:10.1182/blood.v70.1.192.bloodjournal701192 · Cited by 232
Pieters, R., Loonen, A. H., Huismans, D. R., Broekema, G., Dirven, M., Heyenbrok, M., Hählen, K., & Veerman, A. J. P. (1990) · Blood · doi:10.1182/blood.v76.11.2327.2327 · Cited by 232
Self-citationBruhat, A., Jousse, C., Wang, X.-Z., Ron, D., Ferrara, M., & Fafournoux, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17588 · Cited by 198
Establishment of a Ph1-Positive Human Cell Line (BV173)
Pegoraro, L., Matera, L., Ritz, J., Levis, A., Palumbo, A., & Biagini, G. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/70.3.447 · Cited by 153
l-Asparaginase resistance in human leukemia—Asparagine synthetase
Haskell, C. M., & Canellos, G. P. (1969) · Biochemical Pharmacology · doi:10.1016/0006-2952(69)90375-x · Cited by 152
Stams, W. A. G. (2003) · Blood · doi:10.1182/blood-2002-08-2446 · Cited by 149
Aslanian, A. M., Fletcher, B. S., & Kilberg, M. S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3570321 · Cited by 145
Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes
Findley, H. J., Cooper, M. D., Kim, T., Alvarado, C., & Ragab, A. (1982) · Blood · doi:10.1182/blood.v60.6.1305.1305 · Cited by 142
Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells
Marten, N. W., Burke, E. J., Hayden, J. M., & Straus, D. S. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.8.8181673 · Cited by 141
Aslanian, A. M., Fletcher, B. S., & Kilberg, M. S. (2001) · Biochemical Journal · doi:10.1042/bj3570321 · Cited by 131
Hutson, R. G., Kitoh, T., Amador, D. A. M., Cosic, S., Schuster, S. M., & Kilberg, M. S. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.5.c1691 · Cited by 130
Pietro, E. D., Sirois, J., Tremblay, M. L., & MacKenzie, R. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4158-4166.2002 · Cited by 120
Gazzola, G. C., Dall’Asta, V., & Guidotti, G. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69588-8 · Cited by 117
Establishment and characterization of human B cell precursor-leukemia cell lines
Matsuo, Y., & Drexler, H. G. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00050-2 · Cited by 117
Fine, B. M., Stanulla, M., Schrappe, M., Ho, M., Viehmann, S. F., Harbott, J., & Boxer, L. M. (2003) · Blood · doi:10.1182/blood-2003-05-1518 · Cited by 108
Self-citationUphoff, C., MacLeod, R., Denkmann, S. A., Golub, T. R., Borkhardt, A., Janssen, J. W. G., & Drexler, H. G. (1997) · Leukemia · doi:10.1038/sj.leu.2400571 · Cited by 87
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hermans, A., Gow, J. W., Selleri, L., Lindern, M. V., Hagemeijer, A., Wiedemann, L. M., & Grosveld, G. C. (1988) · PubMed · Cited by 76
Aslanian, A. M., & Kilberg, M. S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580059 · Cited by 72
Asselin, B. L., Kreissman, S. G., Coppola, D. J., Bernal, S. D., Leavitt, P., Gelber, R. D., Sallan, S. E., & Cohen, H. J. (1999) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199901000-00003 · Cited by 61
Aslanian, A. M., & Kilberg, M. S. (2001) · Biochemical Journal · doi:10.1042/bj3580059 · Cited by 58
Yang, X. M., & MacKenzie, R. E. (1993) · Biochemistry · doi:10.1021/bi00092a022 · Cited by 54
RCH-ACV: A lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8
Jack, I., Seshadri, R., Garson, M., Michael, P. M., Callen, D. F., Zola, H., & Morley, A. A. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90055-5 · Cited by 52
Kaspers, G. J. L., Kardos, G., Pieters, R., van Zantwijk, C. H., Klumper, E., Hählen, K., de Waal, F. C., van Wering, E. R., & Veerman, A. J. P. (1994) · PubMed · Cited by 52
Self-citationAsparagine synthetase activity in paediatric acute leukaemias: AML‐M5 subtype shows lowest activity
Dübbers, A., Würthwein, G., Müller, H.-J., Schulze-Westhoff, P., Winkelhorst, M., Kurzknabe, E., Lanvers, C., Pieters, R., Kaspers, G. J. L., Creutzig, U., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02015.x · Cited by 51
Self-citationOhyashiki, K., Fujieda, H., Miyauchi, J., Ohyashiki, J. H., Tauchi, T., Saito, M., Nakazawa, S., Abe, K., Yamamoto, K., & Clark, S. (1991) · PubMed · Cited by 49
Naumovski, L., Morgan, R., Hecht, F., Link, M. P., Glader, B. E., & Smith, S. D. (1988) · PubMed · Cited by 40
Włodarska, I., Aventin, A. M., Inglés‐Esteve, J., Falzetti, D., Criel, A. M., Cassiman, J., Mecucci, C., BERGHE, H. V. D., & Marynen, P. (1997) · Blood · doi:10.1182/blood.v89.5.1716 · Cited by 38
Kaspers, G. J. L., Veerman, A. J. P., Pieters, R., et al. (1997) · Blood · doi:10.1182/blood.v90.7.2723.2723_2723_2729 · Cited by 34
Self-citationPeng, H., Shen, N., Qian, L., Sun, X.-L., Koduru, P. R. K., Goodwin, L. O., Issa, J. J., & Broome, J. D. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2000 · Cited by 29
Capizzi, R. L., Summers, W. P., & Bertino, J. R. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46985.x · Cited by 27
t(1;19)(q23;p13) in pre-B acute lymphocytic leukemia cell line 697
Barker, P. E., Carroll, A. J., & Cooper, M. D. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90204-4 · Cited by 25
Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes
Findley, H. J., Cooper, M., Kim, T., et al. (1982) · Blood · doi:10.1182/blood.v60.6.1305.bloodjournal6061305 · Cited by 21
Capizzi, R. L., Summers, W. P., & Bertino, J. R. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb31156.x · Cited by 20
Pieters, R., Loonen, A. H., Huismans, D., et al. (1990) · Blood · doi:10.1182/blood.v76.11.2327.bloodjournal76112327 · Cited by 19
Self-citationMatsuo, Y., Ariyasu, T., OHMOTO, E., Kimura, I., & Minowada, J. (1991) · PubMed · Cited by 16
Włodarska, I., Aventin, A. M., Inglés‐Esteve, J., et al. (1997) · Blood · doi:10.1182/blood.v89.5.1716.1716_1716_1722 · Cited by 3
Cited by
Sorted by citations
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Iwamoto, S., Mihara, K., Downing, J. R., Pui, C., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336
L-Asparaginase: A Promising Chemotherapeutic Agent
Verma, N., Kumar, K., Kaur, G., & Anand, S. (2007) · Critical Reviews in Biotechnology · doi:10.1080/07388550601173926 · Cited by 261
Asparagine Synthetase Chemotherapy
Richards, N. G. J., & Kilberg, M. S. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142520 · Cited by 244
Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations
Avramis, V. I., & Panosyan, E. H. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00003 · Cited by 241
Metadata
- Authors
- Fine, B. M., Kaspers, G. J. L., Ho, M., Loonen, A. H., & Boxer, L. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- VA Palo Alto Health Care System (US)
- Venue
- Cancer Research
- Published
- 2005-01-01
- Volume
- 65
- Issue
- 1
- Pages
- 291-299
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W1867192423
- Cited by
- 103
- References
- 52
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 8 · 2014: 11 · 2012: 5
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institutes of Health (1r01ca092326-01)
- National Cancer Institute (CA85129, CA92326, K08CA095563, U01CA085129)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- L-asparaginase, acute lymphoblastic leukemia, pediatric leukemia, gene expression profiling, asparagine synthetase, drug resistance, tRNA synthetase, amino acid transporters, C/EBP transcription factors, cell proliferation, leukemia cell lines
- MeSH terms
- Adolescent, Antineoplastic Agents, Asparaginase, Child, Female, Humans, Male, Recurrence, Translocation, Genetic, Genome, Human, Artificial Gene Fusion, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review